Nuno Prego Ramos will be one of the speakers at the opening session of BIO-Europe Spring 2026, taking place from March 23 to 25 at FIL, in Lisbon.
The conference, now in its 20th edition, is being held in Portugal for the first time and is one of Europe’s leading partnering events in the life sciences sector. It brings together pharmaceutical and biotechnology companies, investors, universities and research centers to foster strategic partnerships and drive investment. With more than 3,700 participants (such as executives and decision-makers) from around 60 countries already confirmed, Lisbon’s selection reflects the country’s growing position as a credible and competitive hub for life sciences.
An entrepreneur and researcher with a strategic vision for the role Portugal can play in biotechnology, Nuno Prego Ramos is CEO of Valvian, a Portuguese biotech company focused on developing innovative cancer therapies and addressing aging-related challenges.